Professor Sir Aziz Sheikh OBE gives inaugural lecture
Oxford University's Nuffield Department of Primary Care Health Sciences has been one of the world's most important primary care centres for over 20 years. We lead multidisciplinary applied research and training to rethink the way health care is delivered in general practice and across the community both in the UK and internationally.
Understanding, diagnosing and managing COVID-19.
Research for better care in the community.
A dynamic, multidisciplinary team.
Training and professional development opportunities.
News and opinion
Study with us
Research and healthcare leadership programmes
Explore our MSc in Global Healthcare Leadership developing experienced, strategic leaders.
Oxford Qualitative Courses - from specialists in qualitative research methods
Short, online courses from our researchers on the design, conduct and interpretation of qualitative research.
Featured research
-
Role of Physician and Anaesthetic Associates in UK healthcare challenged in largest ever review
A new study has found little evidence supporting the safety and efficacy of physician associates (PAs) and anaesthetists associates (AAs) in the UK, raising critical questions about the rapid expansion of these roles in the NHS.
-
Junk food ads flood children’s social media feeds, new study finds
New research shows children and young people are bombarded with social media ads for junk food, which influence their food choices, but current rules do little to protect them.
-
Largest ever UK study reveals stark ethnic and social inequalities in lung cancer diagnosis
Analysis of 17.5 million health records reveals significant ethnic and social inequalities in lung cancer diagnosis. Research shows Bangladeshi men face highest risks, while people in deprived areas are twice as likely to develop lung cancer compared to affluent areas. Important implications for NHS screening.
-
Weight trends in the pandemic for adults with type 2 diabetes or hypertension: An OpenSAFELY observational study
A new study, published in the British Journal of General Practice, has used the OpenSAFELY platform to uncover significant inequalities in risk of rapid weight gain among adults with type 2 diabetes or hypertension during the COVID-19 pandemic in England.
-
The scale of Long COVID: New study highlights the widespread impact
A comprehensive state-of-the-art review published today in The Lancet has revealed the widespread impact of Long COVID, providing crucial insights into the condition's biological mechanisms and outlining key areas for future research.
-
OpenSAFELY provides vital real-time data to support NHS ambition for safer opioid use
Amid concerns that the COVID-19 pandemic might have led to increases in opioid prescribing, a new study from researchers at the Bennett Institute for Applied Data Science, University of Oxford, demonstrates how the OpenSAFELY database can be used to conduct detailed analyses of opioid prescribing practices, in line with key recommendations from recent NHS England guidance aimed at preventing and reducing opioid harm.
-
New heart disease calculator could save lives by identifying high-risk patients missed by current tools
Collaborative research, led from NDPCHS and published today in Nature Medicine, has developed a new tool called QR4 that more accurately predicts an individual's 10-year risk of cardiovascular diseases, like heart disease and stroke, particularly identifying high-risk patients that current prediction tools miss.
-
New study shows ivermectin lacks meaningful benefits in COVID-19 treatment
New research led by the University of Oxford has concluded that the antiparasitic drug ivermectin does not provide clinically meaningful benefits for treating COVID-19 in a largely vaccinated population.
-
Learning from diverse experiences of COVID-19
We aim to understand how people from diverse backgrounds have experienced COVID-19.
-
SuMMiT-D
Developing a text message-based system to help people with type 2 diabetes to manage their condition.
-
OpenSAFELY analytics platform
OpenSAFELY delivers urgent results during the global COVID-19 emergency and demonstrates the power of modern, open computational data science techniques for healthcare